What is Affusion?
Headquartered in New York City and Philadelphia, Affusion operates as a specialized consultancy that bridges the gap between executive business strategy and technical implementation. The firm distinguishes itself through a dual-focus model, providing deep expertise in business intelligence, risk management, and regulatory compliance. Their consultants are currently embedded within major global enterprises, managing critical infrastructure projects ranging from Dodd-Frank regulatory adherence and trade surveillance to anti-money laundering and Know-Your-Client protocols. By integrating advanced data warehousing with functional business acumen, Affusion has established itself as a vital partner for organizations navigating the complexities of modern healthcare and financial regulations.
How much funding has Affusion raised?
Affusion has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Affusion
PPP
Public-Private Partnership
What's next for Affusion?
With the recent capital injection, Affusion is poised to accelerate its growth trajectory by expanding its footprint in the life sciences and financial services sectors. The firm intends to scale its consulting team to meet the rising demand for sophisticated data governance and compliance frameworks. As global markets face heightened scrutiny, Affusion's strategic focus on business-critical platforms will likely serve as a primary driver for long-term value creation. The firm is expected to prioritize the development of proprietary analytical tools that streamline complex regulatory reporting, further cementing its reputation as a leader in enterprise-grade consulting solutions.
See full Affusion company page
